Search Results - "Leiser, A L"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor by Leiser, A.L, Hamid, A.M, Blanchard, R

    Published in Gynecologic oncology (01-08-2004)
    “…Introduction. Endometrial stromal tumors with sex-cord-like elements are relatively rare. We report a case of this neoplasm with prolactin as a tumor marker…”
    Get full text
    Journal Article
  2. 2

    Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer by Maluf, F C, Leiser, A L, Aghajanian, C, Sabbatini, P, Pezzulli, S, Chi, D S, Wolf, J K, Levenback, C, Loh, E, Spriggs, D R

    “…The aim of this study was to evaluate the activity and toxicity of a tirapazamine (TPZ)/cisplatin drug combination in patients with stage IV or recurrent…”
    Get more information
    Journal Article
  3. 3

    Oxidative stress aspects of the cytotoxicity of carbamide peroxide: in vitro studies by Smensky, M.C., Leiser, A.L., Babich, H.

    Published in Toxicology letters (1995)
    “…Carbamide peroxide is the active ingredient in many at-home patient-applied tooth whiteners. The cytotoxicity of carbamide peroxide, as related to oxidative…”
    Get full text
    Journal Article
  4. 4

    A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer by Leiser, A L, Maluf, F C, Chi, D S, Sabbatini, P, Hensley, M L, Schwartz, L, Venkatraman, E, Spriggs, D, Aghajanian, C

    “…This phase I study sought to determine the toxicity profile, pharmacokinetics, and antitumor activity of giving carboplatin every 3 weeks and paclitaxel weekly…”
    Get more information
    Journal Article
  5. 5

    Eukaryotic elongation factor 1 alpha 2 alone is not sufficient to cause tumorigenicity in immortalized and neoplastic ovarian cell lines by Leiser, A. L., Rosales, N., Spriggs, D.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 15051 Background: EEF1a2 is amplified and overexpressed in 25% of ovarian tumors. Previous studies have shown EEF1a2 to have oncogenic and…”
    Get full text
    Journal Article
  6. 6

    Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma by Leiser, Aliza L., Anderson, Sibyl E., Nonaka, Daisuke, Chuai, Shaokun, Olshen, Adam B., Chi, Dennis S., Soslow, Robert A.

    Published in Gynecologic oncology (01-04-2006)
    “…The primary aim of this study was to investigate the expression of apoptotic and cell cycle regulators p53, p21, p27, bax, and bcl-2 in uterine leiomyosarcoma…”
    Get full text
    Journal Article
  7. 7
  8. 8